Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12-week, double-blind, randomized, placebo-controlled, multicentre trial (Q43104656)
Jump to navigation
Jump to search
scientific article published in April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12-week, double-blind, randomized, placebo-controlled, multicentre trial |
scientific article published in April 2010 |
Statements
1 reference
Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12-week, double-blind, randomized, placebo-controlled, multicentre trial (English)
1 reference
H M R Pattzi
1 reference
S Pitale
1 reference
M Alpizar
1 reference
C Bennett
1 reference
A M O'Farrell
1 reference
J Li
1 reference
J M Cherrington
1 reference
H-P Guler
1 reference
PHX1149-PROT202 Study Group
1 reference
1 April 2010
1 reference
1 reference
Identifiers
1 reference